MedTrace Logo

Pregnancy Outcome Following Global Fibroid Ablation Using the Acessa™ System

NCT03028610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2024-12-09

No results posted yet for this study

Summary

Prospective, interventional, single-center, longitudinal, single-arm pilot study to evaluate pregnancies following the Acessa™ treatment of uterine myomas in women who desire future childbearing

Conditions

  • One or More Uterine Fibroids

Interventions

DEVICE

radiofrequency generator

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Sara Y Brucker, MD · University Women's Hospital, Calwerstrasse 7, 72076 Tübingen, Germany

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2023-07-13
Completion
2023-08-13

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03028610 on ClinicalTrials.gov